A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Clinical trial NCT04257929 · COMPLETED
Trial details
- NCT number
- NCT04257929
- Sponsor
- Harmony Biosciences Management, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2022-08-17
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.